Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
22.35
+0.05 (0.22%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Cartesian Therapeutics Employees
As of December 31, 2023, Cartesian Therapeutics had 38 total employees, including 37 full-time and 1 part-time employees.
Employees
38
Change
n/a
Growth
n/a
Revenue / Employee
$1,423,737
Profits / Employee
-$7,031,526
Market Cap
534.09M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Community Health Systems | 61,000 |
| Auna S.A. | 14,958 |
| Varex Imaging | 2,400 |
| Emergent BioSolutions | 1,600 |
| Sage Therapeutics | 487 |
| Surmodics | 376 |
| Prime Medicine | 234 |
| Arcturus Therapeutics Holdings | 180 |
RNAC News
- 14 days ago - Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting - GlobeNewsWire
- 25 days ago - Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewsWire
- 6 weeks ago - Cartesian Therapeutics Seems A 'Strong Buy' After Positive Phase 2 Results - Seeking Alpha
- 7 weeks ago - Cartesian Therapeutics Announces New Employment Inducement Grant - GlobeNewsWire
- 2 months ago - Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15 - GlobeNewsWire
- 4 months ago - Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik - GlobeNewsWire
- 4 months ago - Cartesian: Further Value To Be Unlocked After Positive MG Treatment Data - Seeking Alpha
- 4 months ago - Cartesian Therapeutics autoimmune disorder therapy meets main goal of mid-stage study - Reuters